Biosensor Compared With Standard Care to Identify Extravasation Injuries in Paediatric Intensive Care: A Randomised Controlled Trial
Authors:
- Craig A. McBrideCMCraig A. McBride
- Sarfaraz RahimanSRSarfaraz Rahiman
- Luregn J. SchlapbachLSLuregn J. Schlapbach
- Jessica A. SchultsJSJessica A. Schults
- Tricia M. KleidonTKTricia M. Kleidon
- Rebecca PatersonRPRebecca Paterson
- Joshua ByrnesJoshua Byrnes
- Robert S. WareRobert S. Ware
- Amanda J. UllmanAUAmanda J. Ullman
Open Access
- 14 April 2026
- journal article
- research article
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 62 (6) , 1034-1043
Abstract
Aim: To evaluate whether, in children treated in paediatric intensive care units (PICU) with peripheral venous access devices (PVADs) receiving intermediate‐ or high‐risk peripheral intravenous medications, the use of a tissue‐infiltration biosensor (ivWatch), compared to standard care, reduces extravasation injuries. Methods: A superiority, parallel group randomised controlled trial conducted in a single Queensland quaternary hospital PICU from September 2020 to July 2022. Children with PVADs inserted in the distal half of the limb and receiving intermediate‐ to high‐risk infusates for ≥ 24 h were randomly allocated in a 1:1 ratio to biosensor (ivWatch monitor applied within 10–15 mm of the PVAD tip) plus standard clinical observation, or standard observation alone. Primary outcome was extravasation severity on the 4‐point Cincinnati Children's Hospital Medical Centre Extravasation Harm Scale. Injuries were compared between treatment groups using ordinal logistic regression. Results: A total of 175 children were enrolled, 88 to biosensor and 87 to standard care. Extravasation severity was similar between groups, with no, mild and moderate injury occurring in 56 (69%), 25 (30%) and 2 (2%) participants in the biosensor group and 61 (70%), 24 (28%) and 2 (2%) in the standard care group (proportional odds ratio = 1.13; 95% CI: 0.59, 2.15, p = 0.71). No statistically significant between‐group differences in extravasation severity, volume, treatment sequelae, PVADs used or dwell time were observed. The biosensor was acceptable to nurses. Conclusions: In this PICU population, biosensor monitoring in addition to standard care did not significantly reduce extravasation injuries. The technology was acceptable to bedside nursing staff. Trial Registration: ACTRN12620000317998Keywords
Funding Information
- Children's Hospital Foundation (RPC0822020)
This publication has 37 references indexed in Scilit:
- Preventing InfusAte injuries throughout a Child's Hospitalization (PATCH): Study protocol for a type 1 hybrid randomized controlled trialJournal of Hospital Medicine, 2025
- Extravasation injury management for neonates and children: A systematic review and aggregated case seriesJournal of Hospital Medicine, 2022
- Effect of Nitric Oxide via Cardiopulmonary Bypass on Ventilator-Free Days in Young Children Undergoing Congenital Heart Disease SurgeryJAMA, 2022
- Incidence of peripheral intravenous catheter failure and complications in paediatric patients: Systematic review and meta analysisInternational Journal of Nursing Studies, 2020
- The longitudinal validity, reproducibility and responsiveness of the Brisbane Burn Scar Impact Profile (caregiver report for young children version) for measuring health-related quality of life in children with burn scarsBurns, 2019
- The Brisbane Burn Scar Impact Profile (child and young person version) for measuring health-related quality of life in children with burn scars: A longitudinal cohort study of reliability, validity and responsivenessBurns, 2019
- The clinimetric properties of the COMFORT scale: A systematic reviewEuropean journal of pain, 2016
- Measuring the impact of burn scarring on health-related quality of life: Development and preliminary content validation of the Brisbane Burn Scar Impact Profile (BBSIP) for children and adultsBurns, 2015
- Peripheral IV Stabilization and the Rate of Complications in Children: An Exploratory StudyJournal of Pediatric Nursing, 2014
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009